Novozymes A/S (LON:0Q4U)

Market Cap	25.17B
Revenue (ttm)	3.39B
Net Income (ttm)	383.57M
Shares Out	n/a
EPS (ttm)	1.32
PE Ratio	65.63
Forward PE	30.82
Dividend	0.70 (0.15%)
Ex-Dividend Date	Apr 4, 2025

Volume	81,898
Average Volume	140,348
Open	457.75
Previous Close	n/a
Day's Range	457.80 - 471.15
52-Week Range	368.60 - 485.60
Beta	0.54
RSI	74.77
Earnings Date	May 8, 2025

About Novozymes

Novozymes A/S produces and sells produces various industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and profe...

• Industry: Miscellaneous Chemical Products
• Founded: 1925
• Employees: 10,582
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q4U

Financial Performance

In 2024, Novozymes's revenue was 3.83 billion, an increase of 59.58% compared to the previous year's 2.40 billion. Earnings were 305.80 million, a decrease of -24.66%.

Financial numbers in EUR